Window-to-China
Overview of last view News
CAS Ningbo Institute of Material Engineering and Technology develops new polymer material for artificial joints stabilized by vitamin E
The material is based on ultra high molecular weight polyethylene stabilized by highly pure vitamin E which prevents destruction of bonds by liposome-activated polyethylene oxide. China’s potential demand for artificial joints is over 3 million units, but in 2013 the actual consumption was about 300,000 units.
CAS news release, September 12, 2014
CAS Institute of Industrial Biotechnology, Tianjin, has developed improved process for alkaline pectinase used in bio-scouring
The recombinant enzyme is produced by high-density culture of E. coli at a level of 4475 U/ml feeding lactose.
CAS news release, September 12, 2014
China plans first manned space station around 2022
As announced during the Annual Meeting of the Association of Space Explorers, that after the launch of the Tiangong-2 space lab around 2016, the Shenzhou-11 spacecraft and Tianzhou-1 cargo spacecraft will be launched to dock with it. Around 2018, a core experimental space module will be launched ahead of the space station being completed in around eight years’ time.
CAS news release, Sept. 9, 2014
Geely Seaview SC7 car wins national price for methanol fuel engine
Geely has started to develop methanol-based engines in 2005. 150 test cars were put in operation in March 2013 and have driven 5,8 million km, with up to 90.000 km/car. Average methanol consumption was 15,3 l/100 km, at a cost of 75 Yuan/l. China’s national strategy is to change the use of coal to chemical products such as methanol. At present, China produces about 50 % of the global methanol.
China Bio news release, Sept. 9, 2014
Novozymes and Shanghai R&D Center of Industrial Biotechnology (CIBT) to collaborate on the development of xylose yeast” for biofuels”
Process development will be based on corn stalks, and Novozymes’ contribution is a “xylose yeast” which metabolizes both gluose and xylose. CIBT uses already corn stalks for the production of bio-butanol using Clostridia
CAS news release, Sept. 5, 2014; Novozymes China press release, August 15, 2014
Development and Reform Commission (NDRC) pushes application of bio-based materials
Within the 12th 5-years’ plan (2011-2015), the NDRC will inject over 220 billion Yuan (about 18 billion €) into bio-based materials engineering projects at CAS, universities and industry, including new business models and national standards. China is the world’s largest producer of wood-plastic composite materials.
CAS news release, Sept. 5, 2014; Novozymes China press release, August 15, 2014
CAS Kunming Institute of Zoology finds salamander peptide good for wound healing
In mice experiments, tylotoin, a 12-aminoacid containing peptide (KCVRQNNKRVCK), was found to promote wound healing by enhancing proliferation of keratinocytes. Tylotoin also promotes the release of transforming growth factor beta1 and interleukin 6, which are essential in the wound healing response.
CAS news release, Sept. 9, 2014
Beijing Wondow Caps Co. starts seaweed polysaccharide-based capsule business
The capsules are used as drug carriers and have several advantages compared to gelatin capsules such as lower moisture content and less interactions with protein drugs such as cross-linking or Maillard reactions.
China Bio news release, Sept. 2, 2014
Phoenix Bio commissioned by Chinese Academy of Social Science to prepare Blue Book on probiotics
Phoenix Bio since its inception in 1996, has focused on probiotics and is a Chinese leader in the field of functional probiotics. The company operates a large research institute with more than 200 R & D personnel. Its strain collection contains 3500 probiotic strains. The Blue Book will outline how to promote a probiotic industry and will develop guidance on standards etc.
China Bio news release, Sept. 2, 2014
Shengli Oilfield reports progress on controlling sulfate-reducing bacteria during polymer flooding
Corrosion by sulfate-reducing bacteria is a major problem in oilfield microbial technology. Sinopec-operated Key Laboratory of MEOR was decorated for developing control strategies for sulfate-producing bacteria which reduced H2S-content in treated sewage to 0.2 mg/L.
China Bio news release, September 2, 2014
China launches birth defects research
MOST announced a research program which will include a database on birth defects in China which will cover 79 major categories. At present, some 900.000 or 5 % of all babies in China are born with birth defects or genetic disorders.
CAS news release, September 2, 2014
China’s funding for young scientists will increase
In view of rising competition from SE Asia, the Chinese government plans to increase funding for scientists under age 45 through its “China National Funds for Distinguished Young Scientists”. A higher part of the budget will be directed directly to the young scientists.
CAS news release, August 25, 2014
CAS will step up foreign researchers to 3 % until 2020
The over 100 CAS institutes employ at present 56.000 researchers (excluding postdocs and visiting scholars) of which 1 % are foreigners. According to CAS Deputy Secretary-General TAN Tieniu, this will be stepped up to 3 % by 2020. In 2014, CAS received 1700 applications from all over the world.
CAS news release, August 25, 2014
Gates Foundation supports TB diagnostic developmen in China with 11 million USD
The Gates Foundation, which has already 20 projects in China, contracts with UStar-Biotechnologies (Hangzhou) to develop low-cost TB molecular detection technology, price target to be half of present international prices.
China Bio news release, August 22, 2014
CAS announces reforms of their institutes
CAS will attempt to streamline their institutes, by removin overlaps and enhancing quality. Wan GANG, Minister of Science and Technology, told Xinhua that, compared with developed countries, China’s science sector is poorly managed and inefficient, with less information sharing and communication; problems that have held back scientific development despite increased investment. The government hopes more commercial enterprises will work with research institutes, but for that to happen, institutes need to be more open and flexible, Wan said. At least 25 companies listed on China’s A-share market are controlled by universities and research institutes with a total market value of about 187.8 billion yuan (30.49 billion US dollars)
CAS news release, August 22, 2014
China Blue Book sees Chinese pharmaceutical marke tat 1,33 trillion Yuan (~100 billion €) in 2014
According to the analysis, online sales of pharmaceuticals reached 4,2 billion Yuan in 2013, and the retail market was 257 billion Yuan. The remainder was sold through hospitals.
China Bio news release, August 22, 2014
Hepatitis B drug „Tifentai“ enters clonical research
The drug, developed by Professor Guangyi LIANG of CAS Key Laboratory of Chemistry for Natural Products in Guizhou, is based on chemically synthesized key components of hepatitis B virus which are easy to produce, and has been shown in preclinical studies to be efficient, have a unique site of action and does not lead to resistance.
Chine Bio news release, August 22, 2014
DICP group achieves solar water splitting using a hybrid of photosystem II and artificial photocatalysis
The groups of Jun CHEN and Can LI at Dalian Institute of Chemical Physics describe a system based on plant PSII and inorganic photocatalysts such as Ru/ SrTiO3:Rh, coupled with an inorganic mediator [ Fe(CN)63−/ Fe(CN)64−], all dispersed in aqueous solutions. PSII seems to self-assembly on the inorganic photocatalyst. The activity of this hybrid photosystem is given with 2,489 mol H2 (mol PSII)−1 h−1 under visible light irradiation and also achieved outdoors.
CAS news release, August 21, 2014
CAS aims to become world-class institution by 2030
According to a CAS statement, will restructure itself to focus on research concerning the strategic demands of the nation and stand at the forefront of global technology. Supervision from a third party and the public will be invited to ensure the transparent use of research funds.
CAS news release, August 20, 2014
China and France to collaborate on virus research
The two countries will jointly construct a top-level biosafety lab in Wuhan, directed towards international emergency response towards the outbreak of epidemic diseases such as Ebola. Health officials and industry practitioners from both countries also discussed potential cooperation in fields such as hospital management, responses to an ageing society and chronic disease intervention.
CAS news release, August 19, 2014